BG Medicine names chief executive officer
This article was originally published in Scrip
Executive Summary
Diagnostic company BG Medicine, which develops cardiovascular tests, has appointed Dr Paul Sohmer president and chief executive officer. Prior to joining Waltham, Massachusetts-based BG, Dr Sohmer was president and CEO of diagnostic and research laboratory, Viracor-IBT Laboratories. He succeeds Eric Bouvier as CEO at BG and will also join the company's board of directors.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.